相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activity of aztreonam in combination with ceftazidime-avibactam against serine- and metallo-β-lactamase-producing Pseudomonas aeruginosa
Michelle Lee et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)
Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales
Amelia Bhatnagar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
In Vitro Activity Comparison of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections With Carbapenem-Resistant Organisms in China
Wei Yu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
Oliver A. Cornely et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam
Frieder Schaumburg et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Juan P. Horcajada et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation
Xiangqing Song et al.
FRONTIERS IN MICROBIOLOGY (2019)
Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients
Gary E. Stein et al.
SURGICAL INFECTIONS (2019)
Avibactam Pharmacokinetic/Pharmacodynamic Targets
Wright W. Nichols et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective
Dinesh Subedi et al.
CLINICAL AND EXPERIMENTAL OPTOMETRY (2018)
Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
John E. Mazuski et al.
CLINICAL INFECTIOUS DISEASES (2016)
Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens
David P. Nicolau et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Pseudomonas aeruginosa: resistance to the max
Keith Poole
FRONTIERS IN MICROBIOLOGY (2011)
Experimental verification of the efficacy of optimized two-step infusion therapy with meropenem using an in vitro pharmacodynamic model and Monte Carlo simulation
Ken Eguchi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2010)
IND-6, a Highly Divergent IND-Type Metallo-β-Lactamase from Chryseobacterium indologenes Strain 597 Isolated in Burkina Faso
Boukare Zeba et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Philip D. Lister et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Genetic and biochemical characterization of the chromosome-encoded class B β-lactamases from Shewanella livingstonensis (SLB-1) and Shewanella frigidimarina (SFB-1)
L Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Metallo-β-lactamase producers in environmental microbiota:: New molecular class B enzyme in Janthinobacterium lividum
GM Rossolini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
